US FDA's Dietary Supplement Programs Deserve A Raise, Trade Groups Tell Senate Appropriators

Compliant industry drove US market growth to $55bn in 2020, and faster growth and higher sales are ahead if FDA’s Office of Dietary Supplement Programs has sufficient funding to eliminate non-compliant businesses.

Five years after the US Food and Drug Administration’s dietary supplements programs got a higher budget profile with an upgrade to an office, industry trade groups tell Senate appropriators the time has come for a funding boost.

Compliant manufacturers and marketers drove the US industry’s growth to $55bn in sales in 2020, and faster growth and higher...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation